The 25,000-square-feet Jefferson Institute for Bioprocessing (JIB) held its ribbon-cutting ceremony, tours and a symposium May 31.
The facility, located in Spring House Innovation Park in Lower Gwynedd, will provide a broad range of training programs beginning next month. It will offer workshops, bioprocessing certifications, and workforce training.
The curriculum adheres to National Institute for Bioprocessing Research and Training requirements.
JIB is aimed at scientists, engineers, and technicians who work in process development and biomanufacturing of biopharmaceuticals and biologics.
Biologics have global revenue totaling more than $200 billion annually and represent about 40 percent of drugs in the pipeline. Biologic pharmaceuticals are manufactured using microorganisms or plant or animal cells, often using DNA technology, and are challenging to produce.
Growth in biologics represents an industry shift from traditional chemical synthesis techniques. Despite this growth, pharmaceutical companies and manufacturers are facing a lack of trained professionals.
“The Jefferson Institute for Bioprocessing is the first example at Jefferson of an academic business unit—one that diversifies the generation of resources aimed at addressing the needs of a rapidly changing society,” Dr. Tykocinski, the Anthony F. and Gertrude M. DePalma Dean of the Sidney Kimmel Medical College, said.
JIB is expected to serve 2,500 students annually.